Publications

Publications keep interested parties informed about the latest scientific, clinical, trial-based, and peer-reviewed documentation about our products and pipeline. Find the latest below:

sort by:

Res Social Adm Pharm.

2019; 15(9): 1126-32

Clinical and economic considerations based on persistency with a novel insulin delivery device versus conventional insulin delivery in patients with type 2 diabetes: A retrospective analysis

view publication

Adv Ther.

2018; 35: 631-43

Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis

view publication

JACC BASIC TRANSLATIONAL SCIENCE

2018; 3(1): 25-34.

Subcutaneous furosemide in heart failure: pharmacokinetic characteristics of a newly buffered solution.

view publication

Diabetes Technol

2018; 20(10): 639-647

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.

view publication

JACC Heart Failure

December 6, 2017, Volume 6 Number 1, Pages 65-70

Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure

view publication

CPT Pharmacometrics Syst. Pharmacol

2017; 6: 365-72

A Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects.

view publication

J. Diabetes Sci. Technol.

2017; 11(1): 157–159

The Need for Faster Insulin: Problem Solved?

view publication

J. Diabetes Sci. Technol

2017; 11(1): 148–156

Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.

view publication

BMJ Open Diabetes Res. Care

2016; 4: e000228

Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled Insulin

view publication

Drugs Real World Outcomes

2016; 3: 191-99

The Clinical and Economic Impact of the V-Go® Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk

view publication

Endocr Pract.

2016; 22(6): 726-35

Clinical and Cost-Effectiveness of Insulin Delivery with V-Go® Disposable Insulin Delivery Device Versus Multiple Daily Injections in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin

view publication

Diabetes Technol. Ther

2016; 18(9): 574–585

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.

view publication
sort by:
<